1. 52Mechanical strain upon aortic valves causes release of danger associated molecular patterns and activates innate immunity. (23rd April 2018) Authors: Tepekoylu, C; Graber, M; Poelzl, L; Hirsch, J; Lobenwein, D; Naegele, F; Fuchs, C; Troppmair, J; Grimm, M; Holfeld, J Journal: Cardiovascular research Issue: Volume 114(2018)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Reliable Experimental Methodology for the Study of Wind-Turbine Rotor Blade Aerodynamics. (May 2019) Authors: Costantini, M; Fuchs, C; Henne, U; Klein, C; Ondrus, V; Bruse, M; Löhr, M; Jacobs, M Journal: Journal of physics Issue: Volume 1222(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA-002Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study. (2nd July 2019) Authors: Tabernero, J; Van Cutsem, E; Bang, Y; Fuchs, C; Wyrwicz, L; Lee, K; Kudaba, I; Garrido, M; Chung, H; Castro Salguero, H; Mansoor, W; Braghiroli, M; Goekkurt, E; Chao, J; Wainberg, Z; Kher, U; Shah, S; Kang, S; Shitara, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LBA-005KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer. (24th June 2018) Authors: Shitara, K; Özgüroğlu, M; Bang, Y J; Di Bartolomeo, M; Mandalà, M; Ryu, M H; Fornaro, L; Olesiński, T; Caglevic, C; Chung, H; Muro, K; Gökkurt, E; Mansoor, W; McDermott, R; Schacham-Shmueli, E; Chen, X; Kang, S P; Mayo, C; Ohtsu, A; Fuchs, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Moderate patient-prosthesis mismatch after valve replacement for severe aortic stenosis has no impact on short-term and long-term mortality. Issue 12 (1st May 2008) Authors: Mascherbauer, J; Rosenhek, R; Fuchs, C; Pernicka, E; Klaar, U; Scholten, C; Heger, M; Wollenek, G; Maurer, G; Baumgartner, H Journal: Heart Issue: Volume 94:Issue 12(2008) Page Start: 1639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O7 Toll-like receptor 3 mediates osteoblastic phenotype switch in calcific aortic valve disease. (30th July 2021) Authors: Gollmann-Tepeköylü, C; Graber, M; Pölzl, L; Hirsch, J; Nägele, F; Naschberger, A; Kirchmair, E; Degenhart, G; Demetz, E; Lobenwein, D; Lener, D; Fuchs, C; Feuchtner, G; Hackl, H; Meyer, D; Grimm, M; Tancevski, I; Holfeld, J Journal: British journal of surgery Issue: Volume 108:Supplement 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Occupational risk factors for symptomatic lumbar disc herniation; a case-control study. Issue 11 (22nd October 2003) Authors: Seidler, A; Bolm-Audorff, U; Siol, T; Henkel, N; Fuchs, C; Schug, H; Leheta, F; Marquardt, G; Schmitt, E; Ulrich, P T; Beck, W; Missalla, A; Elsner, G Journal: Occupational and environmental medicine Issue: Volume 60:Issue 11(2003) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Oscillatory magnetic fields for neutron resonance spin-echo spectroscopy. (15th February 2021) Authors: Jochum, J K; Hecht, A; Soltwedel, O; Fuchs, C; Frank, J; Faulhaber, E; Leiner, J C; Pfleiderer, C; Franz, C Journal: Measurement science & technology Issue: Volume 32:Number 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-094KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer: a double-blind, randomized, placebo-controlled phase 3 study. (2nd July 2019) Authors: Chung, H; Bang, Y; Fuchs, C; Qin, S; Satoh, T; Shitara, K; Tabernero, J; Van Cutsem, E; Cao, Z; Chen, X; Kang, S; Shih, C; Janjigian, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-096A phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585 - Trial in progress. (20th June 2018) Authors: Bang, Y; Van Cutsem, E; Fuchs, C; Ohtsu, A; Tabernero, J; Ilson, D; Hyung, W; Strong, V; Goetze, T; Yoshikawa, T; Tang, L; Hwang, P; Shitara, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗